Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Theralase Technologies Inc.
V.TLT.W
Primary Symbol:
V.TLT
Alternate Symbol(s):
TLTFF
Healthcare
Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called...
Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (TSXV:TLT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(130)
•••
Alamir1111
X
View Profile
View Bullboard History
Comment by
Alamir1111
on Apr 17, 2024 2:47pm
RE:RE:Pp
Thx lesflics. I find it more entertaining reading our in house cancer, venture capitalist experts posts..All the forward looking statements nr's they tend to be boring repetitive.
...more
(56)
•••
lesflics
X
View Profile
View Bullboard History
Comment by
lesflics
on Apr 17, 2024 2:03pm
RE:Pp
Contact Us Theralase® Technologies Inc. Toll Free: 1-866-THE-LASE (843-5273) Local Phone: 416-699-LASE (5273)
Fresh Insight into the Topaz Helium Project's Expected Size and Scale
posted Apr 26, 2024 9:00am by
Pulsar Helium Inc.
-
|
The prospective zone is very broad. We believe its not just an isolated occurrence but is actually something quite regionally extensive ...read more
(130)
•••
Alamir1111
X
View Profile
View Bullboard History
Post by
Alamir1111
on Apr 17, 2024 1:55pm
Pp
Is that supposed pp closed or still ongoing?
(787)
•••
Oilminerdeluxe
X
View Profile
View Bullboard History
Comment by
Oilminerdeluxe
on Apr 17, 2024 12:49pm
RE:RE:RE:RE:RE:Simple and Elegant...
mikee, good fight, man. Winning over that disease a triumph. disease
(259)
•••
BlueFranky
X
View Profile
View Bullboard History
Comment by
BlueFranky
on Apr 17, 2024 12:38pm
RE:RE:RE:RE:Simple and Elegant...
I second those thoughts Great posts, tdon and wildbird! Keep up the good work
(86)
•••
blackjack0
X
View Profile
View Bullboard History
Comment by
blackjack0
on Apr 17, 2024 10:52am
RE:RE:RE:Simple and Elegant...
Great post tdon and wildbird. Much appreciated
(141)
•••
tdon1229
X
View Profile
View Bullboard History
Comment by
tdon1229
on Apr 17, 2024 10:39am
RE:RE:Simple and Elegant...
Mikee3003, First, let me add my voice t those offering congratulations for your successful battle with a blood borne cancer. In 2013, I made contact with my college roommate after 45
...more
(475)
•••
skys1
X
View Profile
View Bullboard History
Comment by
skys1
on Apr 17, 2024 10:09am
RE:RE:RE:RE:RE:Simple and Elegant...
Excellent post wildbird, keep up the good work.
(1004)
•••
wildbird1
X
View Profile
View Bullboard History
Comment by
wildbird1
on Apr 17, 2024 10:00am
RE:RE:RE:RE:Simple and Elegant...
Mikee3003, thank's for responding to my post. I am glad you are doing fine. You seem to be saying that blood cancer is not difficult to treat and that there is numerous effective/safe treatments
...more
(9)
•••
Roadposer
X
View Profile
View Bullboard History
Comment by
Roadposer
on Apr 16, 2024 8:22pm
RE:RE:RE:RE:Simple and Elegant...
No worries mikee
(109)
•••
Mikee3003
X
View Profile
View Bullboard History
Comment by
Mikee3003
on Apr 16, 2024 7:13pm
RE:RE:RE:Simple and Elegant...
Roadposer - Their statement that irked me is just not true! Then to have it repeated and highlited 3 times, just not right. Only pointing out the truth my friend .....
(130)
•••
Alamir1111
X
View Profile
View Bullboard History
Comment by
Alamir1111
on Apr 16, 2024 7:10pm
RE:RE:RE:RE:Simple and Elegant...
For stage I NHL, the 5-year relative survival rate is more than 86%. For stage II the 5-year relative survival rate is 78%, and for stage III it is more than 72%. For stage IV NHL, the 5
...more
(109)
•••
Mikee3003
X
View Profile
View Bullboard History
Comment by
Mikee3003
on Apr 16, 2024 7:04pm
RE:RE:RE:Simple and Elegant...
Much appreciated Eog.....simply pointing out the true fact that there are currently numerous effective/safe treatments for blood cancers.
(3041)
•••
Eoganacht
X
View Profile
View Bullboard History
Comment by
Eoganacht
on Apr 16, 2024 6:15pm
RE:RE:Simple and Elegant...
Thanks for that Mikee3003. It's great to hear a recovery story.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Fresh Insight into the Topaz HELIUM Project's Expected Size and Scale
Exploration company provides project portfolio update